Grants per year
Personal profile
Training Experience
| 2008 | Postdoctoral Fellowship, Vanderbilt University |
Education/Academic qualification
PhD, Shenyang Pharmaceutical University
… → 2002
Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 21 Similar Profiles
Dopamine
Medicine & Life Sciences
Antipsychotic Agents
Medicine & Life Sciences
Phencyclidine
Medicine & Life Sciences
Acetylcholine
Medicine & Life Sciences
Schizophrenia
Medicine & Life Sciences
Prefrontal Cortex
Medicine & Life Sciences
Serotonin
Medicine & Life Sciences
Haloperidol
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 2014 2020
Cognition
Control Groups
Effect of valbenazine, a vesicular monoamine transporter (VMAT2) inhibitor, on neurotransmitter efflux in the medial prefrontal cortex and dorsal striatum of mice
9/26/16 → 9/26/19
Project: Research project
Vesicular Monoamine Transport Proteins
Prefrontal Cortex
Neurotransmitter Agents
Antipsychotic Agents
valbenazine
Rapastinel Mechanism of Action and Effects on Cognitive Function
9/1/16 → 11/22/19
Project: Research project
Ketamine
Cognition
pamidronate
Antidepressive Agents
Phencyclidine
Studies to Investigate the Mechanism of Action of Sunovion Compound SEP-856
4/26/18 → 4/26/19
Project: Research project
Antipsychotic Agents
Psychotic Disorders
Serotonin 5-HT2 Receptor Agonists
Receptor, Serotonin, 5-HT2A
Risperidone
Prot #BIO-17-1142: Contribution of dopamine D3 receptor partial agonism of cariprazine to improve cognition and psychosis
4/15/17 → 4/15/18
Project: Research project
Dopamine D3 Receptors
Psychotic Disorders
Cognition
Antipsychotic Agents
Microdialysis
Research Output 1994 2019
The allosteric dopamine D1 receptor potentiator, DETQ, ameliorates subchronic phencyclidine-induced object recognition memory deficits and enhances cortical acetylcholine efflux in male humanized D1 receptor knock-in mice
Meltzer, H. Y., Rajagopal, L., Matrisciano, F., Hao, J., Svensson, K. A. & Huang, M., Apr 1 2019, In : Behavioural Brain Research. 361, p. 139-150 12 p.Research output: Contribution to journal › Article
Phencyclidine
Dopamine D1 Receptors
Memory Disorders
Acetylcholine
Rivastigmine
1
Citation
(Scopus)
5-HT 1A parital agonism and 5-HT 7 antagonism restore episodic memory in subchronic phencyclidine-treated mice: role of brain glutamate, dopamine, acetylcholine and GABA
Huang, M., Kwon, S., Rajagopal, L., He, W. & Meltzer, H. Y., Oct 1 2018, In : Psychopharmacology. 235, 10, p. 2795-2808 14 p.Research output: Contribution to journal › Article
Phencyclidine
Episodic Memory
gamma-Aminobutyric Acid
Acetylcholine
Glutamic Acid
5
Citations
(Scopus)
Dissecting the Functional Consequences of De Novo DNA Methylation Dynamics in Human Motor Neuron Differentiation and Physiology
Ziller, M. J., Ortega, J. A., Quinlan, K. A., Santos, D. P., Gu, H., Martin, E. J., Galonska, C., Pop, R., Maidl, S., Di Pardo, A., Huang, M., Meltzer, H. Y., Gnirke, A., Heckman, C. J., Meissner, A. & Kiskinis, E., Apr 5 2018, In : Cell Stem Cell. 22, 4, p. 559-574.e9Research output: Contribution to journal › Article
Motor Neurons
DNA Methylation
RNA Sequence Analysis
Pluripotent Stem Cells
Neuronal Plasticity
1
Citation
(Scopus)
TPA-023 attenuates subchronic phencyclidine-induced declarative and reversal learning deficits via GABA A receptor agonist mechanism: possible therapeutic target for cognitive deficit in schizophrenia
Rajagopal, L., Huang, M., Michael, E., Kwon, S. & Meltzer, H. Y., Nov 1 2018, In : Neuropsychopharmacology. 43, 12, p. 2468-2477 10 p.Research output: Contribution to journal › Article
Reversal Learning
GABA-A Receptor Agonists
Phencyclidine
Schizophrenia
Therapeutics
9
Citations
(Scopus)
5-HT 2C Agonists Modulate Schizophrenia-Like Behaviors in Mice
Pogorelov, V. M., Rodriguiz, R. M., Cheng, J., Huang, M., Schmerberg, C. M., Meltzer, H. Y., Roth, B. L., Kozikowski, A. P. & Wetsel, W. C., Apr 12 2017, (Accepted/In press) In : Neuropsychopharmacology.Research output: Contribution to journal › Article
Serotonin Receptor Agonists
Serotonin
Schizophrenia
Receptor, Serotonin, 5-HT2C
Antipsychotic Agents